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Abstract.  Kisspeptin, which is encoded by the Kiss1 gene, and its receptor, the G protein-coupled receptor 54 (Kiss1r), 
play important roles in the regulation of reproductive functions in mammals. Several studies have shown that the Kiss1 and 
Kiss1r genes are expressed in the rat, primate, and human ovaries, and that the ovarian kisspeptin system plays a pivotal role 
in ovulation at the proestrous stage in adulthood. The purpose of this study was to evaluate development-related changes 
in the expression of ovarian Kiss1 and Kiss1r genes and in kisspeptin levels, and to identify the regulatory factors for these 
genes during the prepubertal period. The serum kisspeptin level was also measured to examine whether ovarian kisspeptin 
affects serum kisspeptin levels. Variations in the ovarian Kiss1 and Kiss1r mRNA levels were observed during the prepubertal 
period in female rats, with levels peaking around postnatal days 20 and 15, respectively. Nevertheless, the ovarian kisspeptin 
content per total protein level was stably maintained. Serum kisspeptin levels at postnatal days 30 and 35 were higher than 
those at earlier postnatal days. The pattern of the ovarian Kiss1 mRNA levels was similar to that of the serum luteinizing 
hormone (LH) levels, and the ovarian Kiss1 mRNA level increased after injection with human chorionic gonadotropin (HCG) 
on postnatal day 20, but not on postnatal days 10 and 30. These data indicate that ovarian Kiss1 and Kiss1r mRNA levels are 
increased on postnatal days 20 and 15, respectively, and that changes in the serum LH level and the ovarian sensitivity to LH 
may be involved in the alteration of ovarian Kiss1 mRNA levels.
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 (J. Reprod. Dev. 63: 409–414, 2017) 
Kisspeptin, which is encoded by the Kiss1 gene, and its receptor, the G protein-coupled receptor 54 (Kiss1r), play pivotal roles in 
the regulation of reproductive functions in mammals [1–3]. Kisspeptin 
acts as a stimulator of the gonadotropin-releasing hormone (GnRH) 
in the hypothalamus, and regulates the female ovulatory cycle in 
experimental animals and humans [4, 5]. Kisspeptin and Kiss1r 
are also involved in sexual maturation through the activation of the 
hypothalamic-pituitary-gonadal axis, e.g., of the GnRH-gonadotropin-
gonadal hormone, during the pubertal period in both males and females 
[5]. This relationship between kisspeptin, Kiss1r, and reproductive 
functions was first reported in 2003 [4, 5]. Subsequently, the precise 
mechanism by which hypothalamic kisspeptin regulates GnRH 
secretion, and its involvement in physiological and pathological 
reproductive conditions have been elucidated by rigorous research 
[6–9].
As noted above, although kisspeptin acts primarily at the hypotha-
lamic level to regulate GnRH secretion, it is possible that kisspeptin 
at other sites also plays a role in reproductive functions. Several 
studies have shown that the Kiss1 and Kiss1r genes are expressed 
in rat, primate, and human ovaries [10, 11], and that ovarian Kiss1 
levels and kisspeptin immune reactivities vary drastically based on 
the estrous cycle in female rats [12, 13]. In addition, it has been 
reported that the downregulation of the ovarian Kiss1 gene induces 
ovulatory dysfunction in adult female rats [11, 13]. These data 
indicate that ovarian kisspeptin, as well as hypothalamic kisspeptin, 
may act as positive regulators of ovulation in adulthood. However, 
the expression of ovarian Kiss1 and Kiss1r during the prepubertal 
period have not yet been fully examined. Thus, the purpose of this 
study was to evaluate the developmental changes in the ovarian 
Kiss1/Kiss1r gene expression and the amounts of kisspeptin, and to 
identify the regulatory factors of these genes during the prepubertal 
period. A recent study suggested that the kisspeptin produced in the 
gonadal tissue (testis) may be secreted into the serum in male rats 
[14]. Therefore, we also measured the serum kisspeptin levels during 
the developmental period, and compared their pattern to that of the 
expression of the ovarian Kiss1 gene.
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Materials and Methods
Animals
Pregnant Sprague-Dawley rats were purchased from Charles River 
Japan (Tokyo, Japan) and housed under controlled lighting (12-h light, 
12-h dark; lights on at 0800 h, and off at 2000 h) and temperature 
(24°C) conditions. The day on which the pups were born was defined 
as postnatal day 1. Twelve female pups were randomly assigned to 
a dam on postnatal day 2. The rats were weaned on postnatal day 
21, and housed in groups of three or four per cage. The male pups 
were not used in this study. All animal experiments were conducted 
in accordance with the ethical standards of the animal care and use 
committee of the University of Tokushima.
Experiment 1: Development-related changes in the levels 
of hypothalamic and ovarian Kiss1 and Kiss1r mRNAs, 
ovarian kisspeptin, serum luteinizing hormone (LH), follicle 
stimulating hormone (FSH), and kisspeptin levels
Female rats were randomly selected from each dam or cage on 
postnatal days 10, 15, 20, 25, 30, and 35 (n = 7 to 15 each). They 
were killed by decapitation, and their blood, brain, and ovaries were 
collected between 0900 h and 1100 h. The rat brains and ovaries were 
stored at −80°C, and the sera were stored at −20°C. Thereafter, the 
levels of hypothalamic and ovarian Kiss1 and Kiss1r mRNAs, and 
the (unilateral) ovarian kisspeptin, serum LH, FSH, and kisspeptin 
levels were measured.
Experiment 2: Effects of injection with human chorionic 
gonadotropin (HCG) on ovarian Kiss1 mRNA levels during 
the prepubertal period
Female rats were randomly selected, as described above, on 
postnatal days 10, 20, and 30. Rats at each time point were divided 
into three groups (n = 7 per group). One group was intraperitoneally 
injected with saline, and brain and blood samples were collected 3 
h after injection. The other groups were intraperitoneally injected 
with HCG (10 IU), and the brains and ovaries were collected 3 h 
and 6 h after injection. The samples were stored as described above. 
Thereafter, the hypothalamic and ovarian Kiss1 levels were measured 
as described below.
Serum assay
The serum LH level was measured using a radioimmunoassay (rLH 
[I-125] RIA kit, Institute of Isotopes, Tokyo, Japan). The sensitivity 
of the assay was 0.8 ng/ml, and the inter- and intra-assay coefficients 
of variation (CVs) were 7.7% and 6.5%, respectively. The serum FSH 
level was also measured using a radioimmunoassay (rFSH [I-125] RIA 
kit, Institute of Isotopes). The sensitivity of the assay was 1.6 ng/ml, 
and the inter- and intra-assay CVs were 7.9% and 4.2%, respectively. 
The serum kisspeptin levels were measured using an enzyme linked 
immunosorbent assay (Rat Kisspeptin 1 (KISS1) ELISA Kit, Wuxi 
Donglin Sci&Tech Development, Jiangsu, China). The sensitivity of 
the assay was 31.2 pg/ml, and the inter- and intra-assay CVs were 
< 12%, according to the manufacturer’s instructions.
Quantification of ovarian kisspeptin
Unilateral whole ovaries were homogenized in 500 μl of tissue 
protein extraction buffer (T-PER, Thermo Scientific, Rockford, IL, 
USA). The sample was then centrifuged and the kisspeptin in the 
supernatant was measured using an enzyme linked immunosorbent 
assay (Rat Kisspeptin 1 (KISS1) ELISA Kit, Cusabio Biotech, Wuhan, 
China) and the total amount of ovarian kisspeptin was calculated. The 
sensitivity of the assay was 156 pg/ml, and the inter- and intra-assay 
CVs were < 10% and < 8.0%, respectively. Total protein levels 
were measured in an equal volume of supernatant, using a Pierce 
BCA Protein Assay Kit (Thermo Scientific). The relative level of 
kisspeptin was calculated by dividing the total amount of ovarian 
kisspeptin by the total protein level.
Quantitative real-time polymerase chain reaction (RT-PCR)
Unilateral whole ovary and hypothalamic tissues were used for 
the quantitative real-time polymerase chain reaction. Hypothalamic 
tissues were dissected from frozen brains, as described previously [15]. 
Total RNA was isolated from the ovary and the hypothalamus using 
a TRIzol® reagent kit (Invitrogen, Carlsbad, CA), and an RNeasy® 
mini kit (Qiagen Gmbh, Hilden, Germany). cDNA was synthesized 
with oligo (deoxythymidine) primers at 50°C using the SuperScript 
III first-strand synthesis system for RT-PCR (Invitrogen). PCR 
analysis was performed using the StepOnePlusTM RT-PCR system 
(PE Applied Biosystems, Foster City, CA) and FAST SYBR® green. 
A standard curve was generated by diluting a representative sample, 
and the relative mRNA expression levels were quantified. The mRNA 
expression levels of Kiss1 and Kiss1r in the hypothalamus and ovary 
were normalized to those of GAPDH (hypothalamus) and β-actin 
(ovary), respectively. The forward and reverse primers, and annealing 
temperatures, are summarized in Table 1. The PCR conditions were 
as follows: initial denaturation and enzyme activation at 95°C for 
Table 1. Primer sequences
Primer Sequence Product size Annealing T (ºC)
Kiss1 forward ATG ATC TCG CTG GCT TCT TGG   91 65
Kiss1 reverse GGT TCA CCA CAG GTG CCA TTT T
Kiss1r forward TGT GCA AAT TCG TCA ACT ACA TCC 193 65
Kiss1r reverse AGC ACC GGG GCG GAA ACA GCT GC
GAPDH forward ATG GCA CAG TCA AGG CTG AGA   64 64
GAPDH reverse CGC TCC TGG AAG ATG GTG AT
β-actin forward CCG TAA AGA CCT CTA TGC CAA CA 103 65
β-actin reverse GCT AGG AGC CAG GGC AGT AAT
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20 sec, followed by 45 cycles of denaturation at 95°C for 3 sec, 
annealing for 30 sec, and a final extension step at 72°C for 1 min.
Statistical analyses
All data are presented as the mean ± standard deviation (SD). 
The statistical analyses were performed using a one-way analysis of 
variance (ANOVA), together with the Tukey-Kramer post-hoc test for 
comparison among the groups in Experiment 1. In contrast, a one-way 
ANOVA, together with Dunnett’s test, was used in Experiment 2, 
because HCG-induced changes from the baseline (saline injected 
group) were observed in this experiment. The statistical significance 
was defined as P < 0.05.
Results
Experiment 1: Development-related changes in the levels of 
hypothalamic and ovarian Kiss1 and Kiss1r mRNAs, serum 
LH, and serum kisspeptin
Hypothalamic Kiss1 mRNA levels varied during the developmental 
period (one-way ANOVA, F(5,40) = 2.59; P < 0.05); however, post-hoc 
analyses did not reveal any significant differences among any of the 
examined time points (Fig. 1A). The hypothalamic Kiss1r mRNA 
level did not change during the developmental period (Fig. 1B). The 
ovarian Kiss1 mRNA levels varied during the developmental period 
(one-way ANOVA, F(5,41) = 28.3; P < 0.01), and the Kiss1 mRNA 
level on postnatal day 20 was significantly higher than the levels at 
all other ages (Fig. 1C). Similarly, the ovarian Kiss1r mRNA levels 
also varied during the developmental period (one-way ANOVA, 
F(5,40) = 6.04; P < 0.01), and post-hoc analyses revealed that the 
Kiss1r mRNA level was significantly higher than the Kiss1 mRNA 
level on postnatal day 15, and was also significantly higher than the 
Kiss1r mRNA levels on postnatal days 10, 30, and 35 (Fig. 1D). The 
ovarian kisspeptin content per total protein level varied during the 
developmental period (one-way ANOVA, F(5,44) = 2.58; P < 0.05), 
but post-hoc analyses did not detect any significant differences among 
the values on any postnatal day (Fig. 2). Although serum LH levels 
were not statistically changed (one-way ANOVA, F(5,38) = 2.08; 
P = 0.09) during the developmental period, the serum LH level on 
Fig. 1. Hypothalamic (A, B) and ovarian (C, D) Kiss1 and Kiss1r mRNA levels from day (D) 10 until D35 (n = 7 per group). The mRNA 
levels in the hypothalamus are expressed as values relative to GAPDH, and those in ovary are expressed as values relative to 
β-actin. The mRNA levels at D10 were set as 1.0. Data are presented as the mean ± SD. a, b: different letters indicate different 
significant differences (P < 0.05). **: P < 0.01 vs. all other time points.
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postnatal day 20 was significantly higher than that on postnatal day 
10 (Fig. 3A). On the other hand, serum FSH levels varied during 
the developmental period (one-way ANOVA, F(5,45) = 74.4; P < 
0.01). The serum FSH levels on postnatal days 10 and 15 were 
significantly higher than those on postnatal days 20–35 (Fig. 3B). 
The serum kisspeptin levels varied during the developmental period 
(one-way ANOVA, F(8,63) = 15.5; P < 0.01), and post-hoc analyses 
revealed that the kisspeptin levels on postnatal days 30 and 35 were 
significantly higher than those on postnatal days 10 to 25 (Fig. 4).
Experiment 2: Effects of injection with HCG on ovarian Kiss1 
mRNA levels during the prepubertal period
Hypothalamic Kiss1 mRNA levels did not change after injection 
with HCG on postnatal days 10, 20, and 30 (Figs. 5A–C). In contrast, 
the ovarian Kiss1 mRNA level on postnatal day 20 increased after 
injection with HCG, but this increase was not observed on postnatal 
days 10 or 30 (Figs. 5D–F).
Discussion
In the present study, we showed that the levels of ovarian Kiss1 
and Kiss1r mRNAs varied during development, in the prepubertal 
period in female rats. The expression levels were higher at around 
postnatal days 15 to 20, when compared to the levels on other days. 
This pattern of ovarian Kiss1 mRNA variation was somewhat similar 
to the results of a previous study, showing that ovarian Kiss1 mRNA 
levels on postnatal days 20 to 26 were higher than those on days 29 
and 32 [12]. To the best of our knowledge, the present study is the first 
to show that the Kiss1r mRNA level increases on the same postnatal 
days as Kiss1, although the Kiss1r peak occurred slightly earlier. On 
the other hand, ovarian kisspeptin content per total protein level did not 
change on any experimental day. The present study does not identify 
why the changing patterns of Kiss1 mRNA levels do not correspond 
to changes in the ovarian kisspeptin content per total protein level. 
We speculate that some kisspeptin might be secreted into the plasma, 
and the concentration of kisspeptin might be stably maintained in 
the ovary. Another possibility is that kisspeptin might infiltrate the 
ovary from the blood or other tissues, such as the liver and adipose 
tissues, and that this mechanism maintains stable levels of ovarian 
kisspeptin. The patterns of ovarian Kiss1 and Kiss1r mRNA levels 
differed from those of hypothalamic Kiss1 and Kiss1r mRNA levels 
during the prepubertal period. Therefore, we speculated that ovarian 
Kiss1 and Kiss1r play roles in the development of ovarian functions, 
such as the maturation of ovarian follicles or the increased sensitivity 
to other stimulatory factors, and that ovarian and hypothalamic 
Fig. 2. Ovarian kisspeptin content per total protein level (pg/μg) in 
unilateral ovaries from day (D) 10 until D35 (n = 7–8 per group). 
The ovarian kisspeptin content per total protein level is expressed 
relative to the total protein level. Data are presented as the mean ± 
SD.
Fig. 3. Serum LH (A) and FSH (B) levels from day (D) 10 until D35 
(n = 7–8 per group). Data are presented as the mean ± SD. a–c: 
different letters indicate different significant differences (P < 
0.05).
Fig. 4. Serum kisspeptin levels from day (D) 10 until D35 (n = 7 per 
group). Data are presented as the mean ± SD. a, b: different letters 
indicate different significant differences (P < 0.05).
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Kiss1 and Kiss1r systems may be separately regulated during the 
prepubertal period. However, we cannot exclude the possibility that 
the present study did not detect a pubertal increase in hypothalamic 
Kiss1 mRNA levels, due to an insufficient analysis of the estrous 
cycle after the onset of puberty.
It has been reported that kisspeptin and Kiss1r are mainly distributed 
in the theca layer in adult rats, primates, and humans in adulthood 
[11–13]. It has also been shown that ovarian kisspeptin and Kiss1r 
play pivotal roles in ovulation and in the regulation of the estrous 
cycle in rats. Ovarian Kiss1 and/or Kiss1r mRNA levels increase 
during the proestrous stage, i.e., the ovulatory period, and their 
levels decrease in a high-fat diet-induced anovulatory model [12, 
13]. Because the ovulatory cycle has not yet been established during 
the prepubertal period, the roles of kisspeptin and Kiss1r during this 
period may differ from those in adulthood. Thus, further examination 
is needed to clarify the specific roles of ovarian kisspeptin system 
during sexual maturation.
It has been reported that an increase in ovarian Kiss1 mRNA levels 
in the proestrous stage was prevented by a GnRH antagonist, and 
that its expression level was restored by injection with HCG [12]. 
These data indicated that ovarian Kiss1 mRNA is mainly regulated 
by LH after the establishment of the estrous cycle. Therefore, we 
hypothesized that LH stimulates an increase in the ovarian Kiss1 
mRNA level even during the prepubertal period, and that alterations 
in the LH level itself, or in the sensitivity of the ovarian kisspeptin 
system to LH might be involved in the upregulation of the ovarian 
Kiss1 mRNA levels at around postnatal day 20. As a result, the serum 
LH level increased on postnatal day 20, and the ovarian Kiss1 mRNA 
level increased after injection with HCG at the same time point, in 
the present study. Interestingly, such stimulatory effects of HCG on 
ovarian Kiss1 mRNA levels were not detected at other time points. 
These data indicate that changes in the serum LH level and the ovarian 
sensitivity to LH may be involved in the alteration of ovarian Kiss1 
mRNA levels during the prepubertal period. The changing pattern of 
FSH during the developmental period was dissimilar to that of the 
ovarian Kiss1 mRNA level, and thus, we speculate that FSH may not 
be involved in the regulation of ovarian Kiss1 mRNA. In contrast, 
for Kiss1, the changing pattern of ovarian Kiss1r mRNA levels did 
not correspond to that of serum LH or FSH levels, suggesting that 
Kiss1r mRNA levels might not be regulated by gonadotropins. To our 
knowledge, the factor regulating ovarian Kiss1r gene expression has 
not been identified, and further comprehensive research is required 
to investigate these factors. Interestingly, in addition to the peak 
observed around the weaning period in this study, the ovarian Kiss1r 
mRNA level peaks before that of Kiss1 mRNA, around the time of 
the proestrous luteinizing hormone surge in adult female rats [16]. 
Fig. 5. Hypothalamic (A, B, C) and ovarian (D, E, F) Kiss1 mRNA levels 3 h after saline injection, or 3 h or 6 h after HCG administration 
in rats on days (D) 10 (A, D), D20 (B, E), and D30 (C, F) (n = 7 per group). The mRNA levels in the hypothalamus are expressed as 
values relative to GAPDH, and those in the ovary are expressed as values relative to β-actin. The mRNA levels of the saline-injected 
groups were set as 1.0. Data are presented as the mean ± SD. a, b: different letters indicate different significant differences (P < 0.05).
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Although the physiological roles of such time-course changes in 
Kiss1 and Kiss1r gene expression levels remain unclear, they might 
act in a coordinated manner in the ovary, at each reproductive stage.
Recently, it has been reported that Kiss1 mRNA is also detectable 
in mouse testicular Leydig cells, and that testicular kisspeptin might 
be secreted into the peripheral plasma [14]. It has been reported 
that kisspeptin is produced in other tissues and organs, such as the 
adipose tissue and the liver [17, 18], and that some of the produced 
kisspeptin may be secreted into the plasma [18]. In this study, the 
changing pattern of serum kisspeptin levels did not correspond to 
that of the ovarian kisspeptin content per total protein level. Taken 
together, it is possible that the serum kisspeptin level may not reflect 
the kisspeptin level in a specific tissue or organ, but that it rather 
reflects comprehensive changes in the total production of kisspeptin.
In summary, we showed that the levels of ovarian Kiss1 and 
Kiss1r mRNAs varied during the prepubertal developmental period in 
female rats. Their expression levels peaked at around postnatal days 
15 to 20. The pattern of the ovarian Kiss1 mRNA levels was similar 
to that of the serum LH levels, and the ovarian Kiss1 mRNA level 
increased after injection with HCG on postnatal day 20, but not at 
the other time points. These data indicated that changes in the serum 
LH level and in the ovarian sensitivity to LH may be involved in 
the alteration of ovarian Kiss1 mRNA levels during the prepubertal 
period. On the other hand, the ovarian kisspeptin content per total 
protein level varied little during the developmental period, whereas 
serum kisspeptin levels increased after puberty. Further examination 
is required to clarify the roles of the ovarian kisspeptin system in the 
ovary and other tissues during the developmental period. The present 
results indicate that the ovarian kisspeptin system may play a role 
in the ovary and other peripheral and central reproductive tissues.
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